Brian B. Borg

4.7k total citations
31 papers, 1.2k citations indexed

About

Brian B. Borg is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Brian B. Borg has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 18 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Brian B. Borg's work include Hepatitis C virus research (17 papers), Liver Disease Diagnosis and Treatment (12 papers) and Liver Disease and Transplantation (10 papers). Brian B. Borg is often cited by papers focused on Hepatitis C virus research (17 papers), Liver Disease Diagnosis and Treatment (12 papers) and Liver Disease and Transplantation (10 papers). Brian B. Borg collaborates with scholars based in United States, Malaysia and France. Brian B. Borg's co-authors include T. Jake Liang, David E. Kleiner, Glen Lutchman, Jay H. Hoofnagle, Rohit Loomba, Apurva A. Modi, Nitin Gupta, Gary R. Zuckerman, Bhaskar Banerjee and Theo Heller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and Hepatology.

In The Last Decade

Brian B. Borg

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian B. Borg United States 14 847 519 326 210 179 31 1.2k
Georgia Kafiri Greece 22 712 0.8× 562 1.1× 82 0.3× 259 1.2× 152 0.8× 55 1.3k
Guangqin Xiao China 12 1.0k 1.2× 819 1.6× 162 0.5× 164 0.8× 82 0.5× 21 1.3k
Nobuyuki Torii Japan 18 868 1.0× 597 1.2× 186 0.6× 81 0.4× 173 1.0× 48 1.1k
Shunichiro Fujiyama Japan 21 989 1.2× 887 1.7× 253 0.8× 89 0.4× 165 0.9× 87 1.3k
Seigo Abiru Japan 22 965 1.1× 866 1.7× 82 0.3× 129 0.6× 250 1.4× 52 1.5k
Manabu Daikoku Japan 17 777 0.9× 686 1.3× 70 0.2× 117 0.6× 127 0.7× 28 1.1k
Ki Tae Yoon South Korea 19 767 0.9× 744 1.4× 55 0.2× 157 0.7× 120 0.7× 77 1.2k
Sun Young Yim South Korea 18 457 0.5× 472 0.9× 49 0.2× 88 0.4× 223 1.2× 74 977
Daniela Villari Italy 15 375 0.4× 326 0.6× 89 0.3× 94 0.4× 144 0.8× 42 751
Yoshitaka Takuma Japan 16 680 0.8× 699 1.3× 107 0.3× 60 0.3× 130 0.7× 31 1.0k

Countries citing papers authored by Brian B. Borg

Since Specialization
Citations

This map shows the geographic impact of Brian B. Borg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian B. Borg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian B. Borg more than expected).

Fields of papers citing papers by Brian B. Borg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian B. Borg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian B. Borg. The network helps show where Brian B. Borg may publish in the future.

Co-authorship network of co-authors of Brian B. Borg

This figure shows the co-authorship network connecting the top 25 collaborators of Brian B. Borg. A scholar is included among the top collaborators of Brian B. Borg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian B. Borg. Brian B. Borg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flamm, Steven L., Eric Lawitz, Brian B. Borg, et al.. (2023). Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis. Viruses. 15(10). 2026–2026. 4 indexed citations
2.
Siddiqui, Mohammad Shadab, Michael O. Idowu, Dhruvanshu Parmar, et al.. (2020). A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients With Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology. 19(12). 2670–2672. 64 indexed citations
3.
Flamm, Steven L., Eric Lawitz, Brian B. Borg, et al.. (2019). THU-138-High efficacy and improvement in CPT class with sofosbuvir/velpatasvir plus ribavirin for 12 weeks in patients with CPT C decompensated cirrhosis. Journal of Hepatology. 70(1). e221–e222. 2 indexed citations
4.
Khalili, Mandana, Tania M. Welzel, Glen Lutchman, et al.. (2017). Safety and efficacy of velpatasvir and sofosbuvir with or without ribavirin for the treatment of HCV genotypes 1–6: results of the HCV-TARGET Study. Journal of Hepatology. 66(1). S716–S717. 3 indexed citations
5.
Borg, Brian B., et al.. (2016). Rosai-Dorfman Disease Masquerading as Cholangiocarcinoma. Clinical Gastroenterology and Hepatology. 15(2). e55–e56. 2 indexed citations
6.
Borg, Brian B., et al.. (2013). Bone Mineral Density in Patients with Nonalcoholic Steatohepatitis among End-Stage Liver Disease Patients Awaiting Liver Transplantation. Endocrine Practice. 19(3). 414–419. 5 indexed citations
7.
Kushnir, Vladimir, Pavan Bhat, Reena V. Chokshi, et al.. (2013). The impact of opiate pain medications and psychoactive drugs on the quality of colon preparation in outpatient colonoscopy. Digestive and Liver Disease. 46(1). 56–61. 8 indexed citations
8.
Borg, Brian B., et al.. (2013). Sa1020 Hepatitis B Virus Infection and Risk of Non-Hodgkin Lymphoma: A Meta-Analysis of Case-Control Studies. Gastroenterology. 144(5). S–974. 1 indexed citations
9.
Seetharam, Anil B., Brian B. Borg, Vijay Subramanian, et al.. (2011). Temporal Association Between Increased Virus-Specific Th17 Response and Spontaneous Recovery From Recurrent Hepatitis C in a Liver Transplant Recipient. Transplantation. 92(12). 1364–1370. 15 indexed citations
10.
Lee, Alexander, Nitin Gupta, Brian B. Borg, et al.. (2011). Queue Position in the Endoscopic Schedule Impacts Effectiveness of Colonoscopy. The American Journal of Gastroenterology. 106(8). 1457–1465. 49 indexed citations
11.
Rotman, Yaron, Brian B. Borg, Alejandro Soza, et al.. (2010). Low‐ and standard‐dose peginterferon alfa‐2a for chronic hepatitis C, genotype 2 or 3: efficacy, tolerability, viral kinetics and cytokine response. Alimentary Pharmacology & Therapeutics. 31(9). 1018–1027. 7 indexed citations
12.
Borg, Brian B., Nitin Gupta, Gary R. Zuckerman, Bhaskar Banerjee, & C. Prakash Gyawali. (2009). Impact of Obesity on Bowel Preparation for Colonoscopy. Clinical Gastroenterology and Hepatology. 7(6). 670–675. 115 indexed citations
13.
Yee, Leland J., et al.. (2009). Interleukin-6 haplotypes and the response to therapy of chronic hepatitis C virus infection. Genes and Immunity. 10(4). 365–372. 26 indexed citations
14.
Palmore, Tara N., Neeral L. Shah, Rohit Loomba, et al.. (2009). Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression. Clinical Gastroenterology and Hepatology. 7(10). 1130–1137. 57 indexed citations
15.
Bharat, Ankit, Narayanan Krishnaswamy, Brian B. Borg, et al.. (2008). Characterization of Virus-Specific T-Cell Immunity in Liver Allograft Recipients with HCV-Induced Cirrhosis. American Journal of Transplantation. 8(6). 1214–1220. 12 indexed citations
16.
Turner, Maria L., et al.. (2008). Cutaneous sarcoidosis and primary biliary cirrhosis: A chance association or related diseases?. Journal of the American Academy of Dermatology. 58(2). 326–335. 22 indexed citations
17.
Loomba, Rohit, Glen Lutchman, David E. Kleiner, et al.. (2008). Clinical trial: pilot study of metformin for the treatment of non‐alcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics. 29(2). 172–182. 238 indexed citations
18.
Lutchman, Glen, Apurva A. Modi, David E. Kleiner, et al.. (2007). The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis†. Hepatology. 46(2). 424–429. 181 indexed citations
19.
Yee, Leland J., David E. Kleiner, Dai Wang, et al.. (2007). Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus. Hepatology. 46(1). 74–83. 10 indexed citations
20.
Perumalswami, Ponni, David E. Kleiner, Glen Lutchman, et al.. (2006). Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection†. Hepatology. 43(4). 780–787. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Georgia Kafiri Breakdown of academic impact, for papers by Guangqin Xiao Breakdown of academic impact, for papers by Nobuyuki Torii Breakdown of academic impact, for papers by Shunichiro Fujiyama Breakdown of academic impact, for papers by Seigo Abiru Breakdown of academic impact, for papers by Manabu Daikoku Breakdown of academic impact, for papers by Ki Tae Yoon Breakdown of academic impact, for papers by Sun Young Yim Breakdown of academic impact, for papers by Daniela Villari Breakdown of academic impact, for papers by Yoshitaka Takuma
Rankless by CCL
2026